These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21683096)

  • 1. Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.
    Brouwers J; Vermeire K; Grammen C; Schols D; Augustijns P
    Antiviral Res; 2011 Aug; 91(2):217-23. PubMed ID: 21683096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
    Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
    Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
    Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
    Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    Biomacromolecules; 2008 Jan; 9(1):305-13. PubMed ID: 18072746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.
    Hosny KM; Hassan AH
    Int J Pharm; 2014 Nov; 475(1-2):191-7. PubMed ID: 25178831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
    Boudad H; Legrand P; Lebas G; Cheron M; Duchêne D; Ponchel G
    Int J Pharm; 2001 May; 218(1-2):113-24. PubMed ID: 11337155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients.
    Grammen C; Augustijns P; Brouwers J
    Antiviral Res; 2012 Nov; 96(2):226-33. PubMed ID: 23000496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of supersaturation for the vaginal application of microbicides: a case study with dapivirine.
    Grammen C; Plum J; Van Den Brande J; Darville N; Augustyns K; Augustijns P; Brouwers J
    J Pharm Sci; 2014 Nov; 103(11):3696-3703. PubMed ID: 25231545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and physicochemical characterization of saquinavir mesylate solid dispersions using Gelucire 44/14 or PEG 4000 as carrier.
    Caon T; Konig RA; da Cruz AC; Cardoso SG; Campos CE; Cuffini SL; Koester LS; Simões CM
    Arch Pharm Res; 2013 Sep; 36(9):1113-25. PubMed ID: 23700292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells.
    Yang S; Chen Y; Gu K; Dash A; Sayre CL; Davies NM; Ho EA
    Int J Nanomedicine; 2013; 8():2847-58. PubMed ID: 23966779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
    Griffin BT; O'Driscoll CM
    J Pharm Pharmacol; 2006 Jul; 58(7):917-25. PubMed ID: 16805951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
    Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
    Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmaceutical excipients on in vitro association of saquinavir to chylomicrons.
    Ro J; Kim H; Hwang SH; Yun G; Lee J
    Pharmazie; 2014 Oct; 69(10):745-6. PubMed ID: 25985563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
    Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
    Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereocontrolled synthesis and biological activity of two diastereoisomers of the potent HIV-1 protease inhibitor saquinavir.
    Righi G; Ciambrone S; Bonini C; Campaner P
    Bioorg Med Chem; 2008 Jan; 16(2):902-8. PubMed ID: 17964171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV-1 protease dimer/saquinavir complex.
    Prashar V; Bihani SC; Das A; Rao DR; Hosur MV
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1018-23. PubMed ID: 20471372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin.
    Bilensoy E; Rouf MA; Vural I; Hincal AA
    J Control Release; 2006 Nov; 116(2):e107-9. PubMed ID: 17718942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.